ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

EMBC Embecta Corporation

10,20
0,05 (0,49%)
Zuletzt aktualisiert: 17:21:06
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Embecta Corporation EMBC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,05 0,49% 10,20 17:21:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
10,23 10,15 10,38 10,15
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202423:00GLOBEembecta to Participate in Investor Events
23.4.202423:00GLOBEembecta to Report Fiscal Second Quarter 2024 Financial..
06.3.202412:00GLOBEembecta-sponsored Educational Symposium and Abstracts at..
14.2.202416:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:30EDGAR2Form 8-K - Current report
09.2.202418:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.2.202412:52EDGAR2Form 8-K - Current report
09.2.202412:30GLOBEEmbecta Corp. Reports First Quarter Fiscal 2024 Financial..
09.2.202412:00GLOBEembecta Announces Quarterly Cash Dividend
07.2.202423:00GLOBEembecta to Participate in the 11th Annual BTIG MedTech..
24.1.202423:00GLOBEembecta to Report Fiscal First Quarter 2024 Financial..
09.1.202412:00GLOBEembecta Announces FDA 510(k) Submission for Insulin Patch..
19.12.202322:18EDGAR2Form ARS - Annual Report to Security Holders
19.12.202322:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19.12.202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
14.12.202323:00GLOBEembecta to Participate at the 42nd Annual J.P. Morgan..
01.12.202312:00GLOBENo embecta-made syringes impacted by FDA safety..
29.11.202323:00GLOBEembecta to Participate in Investor Conferences
29.11.202322:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.11.202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202302:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202312:11EDGAR2Form 8-K - Current report
21.11.202311:30GLOBEEmbecta Corp. Reports Fiscal 2023 Fourth Quarter and Full..
21.11.202311:00GLOBEembecta Announces Quarterly Cash Dividend
31.10.202311:50GLOBEembecta to Recognize National Diabetes Awareness Month by..
25.10.202323:00GLOBEembecta to Report Fiscal Fourth Quarter and Full Year 2023..
06.9.202323:00GLOBEembecta to Participate at the Morgan Stanley 21st Annual..
10.8.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202319:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202313:06EDGAR2Form 8-K - Current report
08.8.202312:30GLOBEEmbecta Corp. Reports Third Quarter Fiscal 2023 Financial..
08.8.202312:00GLOBEembecta Announces Quarterly Cash Dividend
03.8.202322:16EDGAR2Form 8-K - Current report
11.7.202323:00GLOBEembecta to Report Fiscal Third Quarter 2023 Financial..
05.7.202323:10EDGAR2Form 8-K - Current report
15.5.202323:38GLOBEUPDATE -- embecta to Participate in Investor Conferences
15.5.202323:00GLOBEembecta to Participate in Investor Conferences
12.5.202312:30GLOBEEmbecta Corp. Reports Second Quarter Fiscal 2023 Financial..
12.5.202312:15GLOBEembecta and Tidepool partner to develop automated insulin..
12.5.202312:00GLOBEembecta Announces Quarterly Cash Dividend

Kürzlich von Ihnen besucht

Delayed Upgrade Clock